Back

The need for add-on oral therapy: patient cases.

28 August 2021 (19:14 - 19:20)
Organised by:
Congress Presentation Part of: Add on to take back control: Combining lipid lowering therapies for the management of high and very high risk patients Lipids Open Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Professor Ulrich Laufs

University Hospital Leipzig, Leipzig (Germany)

6 More presentations in this session

Presentation thumbnail
Welcome and introduction.
Professor K. Ray (London, GB)
Presentation thumbnail
Reflections on SANTORINI.
Professor K. Ray (London, GB)
Presentation thumbnail
Patient background considerations and unmet need.
Professor E. Stroes (Amsterdam, NL)
Presentation thumbnail
Expectations for managing patient outcomes.
Professor U. Laufs (Leipzig, DE)
Presentation thumbnail
Understanding the landscape and need to implement guidelines.
Professor K. Ray (London, GB)

Access the full session

Session thumbnail
Add on to take back control: Combining lipid lowering therapies for the management of high and very high risk patients
Video

The Event

Event poster

ESC Congress 2021 - The Digital Experience

28 August 2021 19:14 CET
You may be interested in
thumbnail
Congress Presentation
Sotatercept as an alternative therapeutic strategy in high-risk pulmonary hypertension associated with systemic sclerosis and interstitial lung disease when prostacyclin therapy is not feasible
29 August 2026
thumbnail
Congress Presentation
Single vs. dual antithrombotic therapy in patients with stabilized coronary artery disease requiring long-term oral anticoagulation: A Bayesian meta-analysis
30 August 2026
thumbnail
Congress Presentation
Conclusion.
28 August 2022
thumbnail
Congress Presentation
The patient behind the fourth drug question
29 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources